A coordinated strategy to scale-up advanced therapies for patient in Manchester
Lead Participant:
THE CHRISTIE NHS FOUNDATION TRUST
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| THE CHRISTIE NHS FOUNDATION TRUST | £252,199 | £ 252,199 |
Participant |
||
| INSTIL BIO (UK) LIMITED | £713,963 | £ 499,773 |
| MANCHESTER UNIVERSITY NHS FOUNDATION TRUST | £270,594 | £ 270,594 |
| ASTRAZENECA UK LIMITED | ||
| SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST | ||
| APTUS CLINICAL LIMITED | £179,161 | £ 125,413 |
| GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD | £52,514 | £ 26,257 |
| AGENTUS THERAPEUTICS LTD | ||
| THE CHRISTIE PATHOLOGY PARTNERSHIP LLP | £41,339 | £ 24,803 |
| CHAUCER GROUP LIMITED | ||
| FORMEDIX LIMITED | ||
| THE UNIVERSITY OF MANCHESTER | £560,476 | £ 560,476 |
| DATATRIAL LIMITED |
People |
ORCID iD |
| Victoria Sheard (Project Manager) |